• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SYRS

SYRS

Syros Pharmaceuticals, Inc.

OTCHealthcareBiotechnologyUS

USD0.00

+0.00 (+19900.00%)

Company Profile

CEO

James E. Bradner

IPO Date

2016-06-30

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.00

Prev. Close

$0.00

Day Low

$0.00

Day High

$0.00

52W Low

$0.00

52W High

$0.04

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

11.7%

Avg Negative

2.7%

Avg Neutral

85.9%

News Feed

Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

Business Wire·7/29/2021·↑ positive

Syros: Pivotal Trial In MDS Ongoing

Seeking Alpha·6/25/2021·↑ positive

9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290%

PennyStocks·6/24/2021·↑ positive

Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference

Business Wire·6/9/2021·↑ positive

SYRS Stock Price: 17.17% Increase Explanation

Pulse2·5/28/2021·↑ positive

Reddit Penny Stocks You Might've Missed In May 2021

PennyStocks·5/27/2021·↓ negative

Syros to Host Key Opinion Leader Webcast Series on Targeted Hematology Portfolio

Business Wire·5/19/2021·↑ positive

Syros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/6/2021·↑ positive

Syros to Report First Quarter 2021 Financial Results on Thursday May 6, 2021

Business Wire·4/29/2021·↑ positive